Taiwan Electrocardiograph (ECG) Market Size and Share
| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 12.15 Million |
| Market Size (2030) | USD 15.45 Million |
| CAGR (2025 - 2030) | 4.92% |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Taiwan Electrocardiograph (ECG) Market Analysis by Mordor Intelligence
The Taiwan Electrocardiograph Market size is estimated at USD 12.15 million in 2025, and is expected to reach USD 15.45 million by 2030, at a CAGR of 4.92% during the forecast period (2025-2030).
The Taiwan electrocardiograph (ECG) market growth is driven by the increasing prevalence of cardiovascular diseases and the adoption of innovative healthcare technologies. A growing focus on early diagnosis and efficient management of heart-related conditions characterizes the market. With the integration of artificial intelligence (AI) and portable monitoring devices, the ECG market in Taiwan is evolving to meet the rising demand for accurate and accessible diagnostic solutions. Additionally, collaborations between healthcare providers and technology companies are further propelling the market's growth trajectory.
The increasing prevalence of cardiovascular diseases, such as atherosclerotic cardiovascular disease (ASCVD), is a major driver of the Taiwan ECG market. For instance, according to the European Chamber of Commerce Taiwan (ECCT) report published in April 2024, ASCVD is a critical public health concern, with 40% of the population at risk. The report highlighted four modifiable risk factors that are highly prevalent in Taiwan: hyperlipidemia (44-58%), hypertension (25%), diabetes (10%), and smoking (13%) in 2023. These alarming statistics underscore the urgent need for advanced diagnostic tools like ECG devices to enable early detection and management of cardiovascular conditions, thereby driving market growth.
Furthermore, strategic collaboration to expand product outreach are significantly influencing the Taiwan ECG market. For instance, in September 2024, the Taiwan Buddhist Tzu-Chi Foundation partnered with Foxconn Technology Group to launch a technology-driven healthcare initiative. This initiative utilizes Foxconn’s hardware health monitoring system, which integrates multiple health metrics, including electrocardiograms, heart rate, blood pressure, and blood glucose. Such advancements are enhancing the accuracy and efficiency of health monitoring, thereby increasing the adoption of ECG devices in Taiwan's healthcare sector.
Moreover, the integration of artificial intelligence in monitoring devices such as ECG is propelling its demand in Taiwan market. For instance, in April 2024, the Sleep Medicine Center at China Medical University Hospital (CMUH) introduced iDREAM (Intelligent Detection of Respiratory Events through Automated Monitoring). This system incorporates Quanta’s QOCA Portable ECG Monitoring Device to detect symptoms of apnea patients while they are asleep at home. Clinical trials involving over 100 patients demonstrated the effectiveness of this AI-powered ECG analysis in accurately diagnosing obstructive sleep apnea syndrome (OSAS). By reducing the time required for diagnosis and treatment, such innovations are boosting the adoption of ECG devices in Taiwan.
Therefore, the Taiwan ECG market is poised to growth, driven by the rising prevalence of cardiovascular diseases, strategic collaborations, and the integration of AI. The increasing demand for accurate and efficient diagnostic tools is fostering collaborations between healthcare providers and technology companies, further accelerating market development. With a strong focus on innovation and early diagnosis, the Taiwan ECG market is expected to play a pivotal role in addressing the growing burden of cardiovascular diseases in the region. However, the high cost associated with advanced ECG devices may act as a barrier, potentially limiting the market's expansion in the country during the same period.
Taiwan Electrocardiograph (ECG) Market Trends and Insights
Holter ECG Systems Segment is Expected to Have Significant Growth in the Market Over the Forecast Period
The Holter ECG systems segment growth is attributed to the growing demand for advanced diagnostic tools in cardiac care. These systems are widely utilized for continuous monitoring of heart activity, enabling healthcare professionals to detect and manage cardiac conditions effectively. With advancements in technology and increasing awareness of cardiovascular diseases, the adoption of Holter ECG systems has been steadily rising in Taiwan.
The rising incidence of cardiovascular diseases, including atrial fibrillation (AF) and heart failure (HF), is driving the need for continuous cardiac monitoring systems such as Holter ECG systems in Taiwan. For instance, a study published in March 2024 by the Official Journal of the Taiwan Society of Cardiology reported that the heart failure (HF) hospitalization rate in Taiwan was between 10-20% in 2023. This growing burden of cardiac conditions necessitates advanced diagnostic tools like Holter ECG systems, which provide continuous monitoring and aid in early detection and management, thereby boosting the holter ECG segemnt in the overall market.
Furthermore, the integration of convolutional neural network (CNN) models with ECG systems has enhanced the diagnostic capabilities of Holter ECG devices. For instance, a study conducted in Taiwan and published in April 2025 by Computers in Biology and Medicine demonstrated the effectiveness of CNN-based ECG models in estimating both past and future risks of atrial fibrillation (AF) by analyzing 12-lead and Holter ECG data. These advancements have made Holter ECG systems more reliable and efficient, driving their adoption in Taiwan's healthcare sector. Furthermore, the study highlighted that patient predicted to have AF faced increased risks of stroke, HF hospitalization, and myocardial infarction (MI), emphasizing the importance of accurate and continuous cardiac monitoring devices such as Holter ECG system. This, in turn, is anticipated to bolster the growth of the studied segment in Taiwan over the forecast period.
Moreover, the healthcare industry in Taiwan is increasingly emphasizing preventive care to reduce the burden of chronic diseases. Holter ECG systems, with their ability to provide continuous and detailed cardiac monitoring, align with this trend by enabling early detection of arrhythmias and other cardiac abnormalities. This proactive approach to healthcare is expected to further boost the demand for Holter ECG systems in the Taiwan market.
ECG Management Software is Expected to Have Fastest Growth in the Market Over the Forecast Period
The ECG management software segment's growth is driven by advancements in healthcare technology and the increasing prevalence of cardiovascular diseases. This segment focuses on improving the efficiency and accuracy of ECG data management, enabling healthcare providers to deliver better patient outcomes. The integration of artificial intelligence (AI) and cloud-based solutions has further enhanced the capabilities of ECG management software, making it a vital component of Taiwan's healthcare infrastructure.
The rising prevalence of cardiovascular diseases, including hypertension, is a significant driver for the growth of ECG management software in Taiwan. For instance, an article published in the Journal of the Formosan Medical Association, in March 2025, highlighted a nearly 6% rise in elderly hypertension prevalence in Taiwan over the past 25 years. This development signals a growing demand for advanced cardiac monitoring solutions, which is projected to accelerate the adoption of ECG devices equipped with ECG management software, driving segment growth.
Furthermore, the adoption of advanced technologies, including AI, has significantly improved the functionality of ECG management software in Taiwan. For instance, in September 2024, Foxconn’s CoDoctor Pro received Class II medical device approval from the Taiwan Food and Drug Administration (TFDA). Foxconn collaborated with hospitals to develop the CoDoctor AI multi-modal medical diagnostic platform, which integrates electrocardiograms. This platform enhances diagnostic accuracy and efficiency, demonstrating the potential of AI-driven ECG management software in addressing the growing demand for precise and reliable diagnostic tools.
Moreover, the deployment of AI-assisted diagnosis systems in emergency medical services has further propelled the adoption of ECG Management Software in Taiwan. For instance, in March 2023, the Central Taiwan Cardiac Rescue AI Network introduced an AI diagnosis system for acute ST-segment elevation myocardial infarction (STEMI). This system allows paramedics to perform electrocardiograms (ECGs) and transmit the data to the cloud in real-time. By integrating this technology into ambulances, healthcare providers can ensure rapid and accurate diagnosis, ultimately improving patient outcomes and driving the demand for ECG management software.
Therefore, the segment's growth is driven by the increasing prevalence of cardiovascular diseases, advancements in AI technology, and the implementation of AI-assisted diagnosis systems. These factors collectively highlight the critical role of ECG management software in enhancing diagnostic accuracy and efficiency.
Competitive Landscape
The competitive landscape of the electrocardiograph (ECG) market in Taiwan is characterized by a mix of established companies and emerging players. The market is semi-consolidated yet dynamically competitive. Additionally, many companies offer specialized solutions, contributing to a vibrant and evolving ecosystem. Some of the major players in the market include Nihon Kohden Corporation, Koninklijke Philips N.V., GE HealthCare, SCHILLER, and Contec Medical Systems Co., Ltd, among others.
Taiwan Electrocardiograph (ECG) Industry Leaders
-
GE HealthCare
-
Koninklijke Philips NV
-
Nihon Kohden Corporation
-
SCHILLER
-
Contec Medical Systems Co., Ltd
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- November 2024: BriteMED Technology Inc. introduced the Wireless 12-Lead Portable ECG in Taiwan. This device captures detailed 12-lead ECG data, supporting the diagnosis of various cardiac conditions, such as arrhythmias and myocardial infarctions.
- September 2024: National Cheng Kung University's Department of Electrical Engineering launched YuGuard, a wireless, wearable patch designed for arrhythmia identification, at Healthcare Expo Taiwan. YuGuard integrates with a heart health management system, providing ECG analysis and cardiac disease detection. The system includes IoT-based hardware, a user-friendly application interface, a cloud database, and an AI-driven platform for cardiac disease identification.
Taiwan Electrocardiograph (ECG) Market Report Scope
As per the scope of the report, an electrocardiograph (ECG) is a medical device used to record the heart's electrical activity. The device captures the heart's electrical signals and produces a graphical representation known as an electrocardiogram.
The Taiwan electrocardiograph (ECG) market report provides a comprehensive analysis of the current state and growth potential of the ECG market in the country. The Taiwan electrocardiograph (ECG) market is segmented by product type, which includes resting (12-lead ECG) systems, stress ECG systems, Holter ECG systems, and ECG management software. The report offers the market size in terms of both value (in USD) and volume (in units) for the above segments.
| Resting ECG Systems |
| Stress ECG Systems |
| Holter ECG Systems |
| ECG Management Software |
| By Product Type | Resting ECG Systems |
| Stress ECG Systems | |
| Holter ECG Systems | |
| ECG Management Software |
Key Questions Answered in the Report
How big is the Taiwan Electrocardiograph Market?
The Taiwan Electrocardiograph Market size is expected to reach USD 12.15 million in 2025 and grow at a CAGR of 4.92% to reach USD 15.45 million by 2030.
What is the current Taiwan Electrocardiograph Market size?
In 2025, the Taiwan Electrocardiograph Market size is expected to reach USD 12.15 million.
Who are the key players in Taiwan Electrocardiograph Market?
GE HealthCare, Koninklijke Philips NV, Nihon Kohden Corporation, SCHILLER and Contec Medical Systems Co., Ltd are the major companies operating in the Taiwan Electrocardiograph Market.
What years does this Taiwan Electrocardiograph Market cover, and what was the market size in 2024?
In 2024, the Taiwan Electrocardiograph Market size was estimated at USD 11.55 million. The report covers the Taiwan Electrocardiograph Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Taiwan Electrocardiograph Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
Taiwan Electrocardiograph (ECG) Market Report
Statistics for the 2025 Taiwan Electrocardiograph (ECG) market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Taiwan Electrocardiograph (ECG) analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
